Research on immunotherapy conducted at the Department of Oncology is presented in a feature article in the popular national Norwegian newspaper Verdens Gang (VG) January 9th. The article focuses on recent progress in chimeric antigen receptor (CAR) T cell therapy. For two years, children with leukemia and adults with lymphoma has been treated through clinical studies. Now the project will be expanded with three new studies on lymphomas.
The article in VG (in Norwegian):
Her utvikler norske kreftleger fremtidens medisin
("Here Norwegian cancer therapists develop cancer medicine of the future")
About Adoptive T-cell therapy (CAR) (from the Section of Cell Therapy home page)